Protein 4.2 : A complex linker

Blood Cells, Molecules, and Diseases

Volumn 42, Issue 3, 2009, Pages 201-210

  Satchwell, Timothy J ^a   Shoemark, Debbie K ^a   Sessions, Richard B ^a   Toye, Ashley M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Erythropoiesis; Hereditary spherocytosis (HS); Protein 4.2; Red blood cells; Transglutaminase family

Indexed keywords

ANKYRIN; ERYTHROCYTE BAND 4.2 PROTEIN; RHESUS ANTIGEN;

AMINO ACID SEQUENCE; ERYTHROCYTE MEMBRANE; HEREDITARY SPHEROCYTOSIS; HUMAN; MEMBRANE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD47; BLOOD PROTEINS; CELL SHAPE; CELL SURVIVAL; CYTOSKELETAL PROTEINS; CYTOSKELETON; ERYTHROCYTE MEMBRANE; HUMANS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPHEROCYTES; SPHEROCYTOSIS, HEREDITARY; TRANSGLUTAMINASES;

MUS;

EID: 64649092658     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2009.01.005     Document Type: Review

References (94)

1. Yawata Y. Cell Membrane- The Red Blood Cell as a Model (2003), Wiley-VCH
2. Korsgren C., and Cohen C.M. Organization of the gene for human erythrocyte membrane protein 4.2: structural similarities with the gene for the a subunit of factor XIII. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 4840-4844
3. Cohen C.M., Dotimas E., and Korsgren C. Human erythrocyte membrane protein band 4.2 (pallidin). Semin. Hematol. 30 (1993) 119-137
4. Korsgren C., Lawler J., Lambert S., Speicher D., and Cohen C.M. Complete amino acid sequence and homologies of human erythrocyte membrane protein band 4.2. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 613-617
5. Sung L.A., Chien S., Chang L.S., Lambert K., Bliss S.A., Bouhassira E.E., Nagel R.L., Schwartz R.S., and Rybicki A.C. Molecular cloning of human protein 4.2: a major component of the erythrocyte membrane. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 955-959
6. Toye A.M., Ghosh S., Young M.T., Jones G.K., Sessions R.B., Ramauge M., Leclerc P., Basu J., Delaunay J., and Tanner M.J. Protein-4.2 association with band 3 (AE1, SLCA4) in Xenopus oocytes: effects of three natural protein-4.2 mutations associated with hemolytic anemia. Blood 105 (2005) 4088-4095
7. Risinger M.A., Dotimas E.M., and Cohen C.M. Human erythrocyte protein 4.2, a high copy number membrane protein, is N-myristylated. J. Biol. Chem. 267 (1992) 5680-5685
8. Das A.K., Bhattacharya R., Kundu M., Chakrabarti P., and Basu J. Human erythrocyte membrane protein 4.2 is palmitoylated. Eur. J. Biochem. 224 (1994) 575-580
9. Korsgren C., and Cohen C.M. Purification and properties of human erythrocyte band 4.2. Association with the cytoplasmic domain of band 3. J. Biol. Chem. 261 (1986) 5536-5543
10. Korsgren C., and Cohen C.M. Associations of human erythrocyte band 4.2. Binding to ankyrin and to the cytoplasmic domain of band 3. J. Biol. Chem. 263 (1988) 10212-10218
11. Golan D.E., Corbett J.D., Korsgren C., Thatte H.S., Hayette S., Yawata Y., and Cohen C.M. Control of band 3 lateral and rotational mobility by band 4.2 in intact erythrocytes: release of band 3 oligomers from low-affinity binding sites. Biophys. J. 70 (1996) 1534-1542
12. Mandal D., Moitra P.K., and Basu J. Mapping of a spectrin-binding domain of human erythrocyte membrane protein 4.2. Biochem. J. 364 (2002) 841-847
13. Bruce L.J., Ghosh S., King M.J., Layton D.M., Mawby W.J., Stewart G.W., Oldenborg P.A., Delaunay J., and Tanner M.J. Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. Blood 100 (2002) 1878-1885
14. Mouro-Chanteloup I., Delaunay J., Gane P., Nicolas V., Johansen M., Brown E.J., Peters L.L., Van Kim C.L., Cartron J.P., and Colin Y. Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47. Blood 101 (2003) 338-344
15. Yawata Y. Band 4.2 abnormalities in human red cells. Am. J. Med. Sci. 307 (1994) 190-203
16. Dahl K.N., Parthasarathy R., Westhoff C.M., Layton D.M., and Discher D.E. Protein 4.2 is critical to CD47-membrane skeleton attachment in human red cells. Blood 103 (2004) 1131-1136
17. Eber S., and Lux S.E. Hereditary spherocytosis-defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin. Hematol. 41 (2004) 118-141
18. An X., and Mohandas N. Disorders of red cell membrane. Br. J. Haematol. 141 (2008) 367-375
19. Gallagher P.G. Red cell membrane disorders. Hematol. Am. Soc. Hematol. Educ. Program (2005) 13-18
20. Perrotta S., Gallagher P.G., and Mohandas N. Hereditary spherocytosis. Lancet 372 (2008) 1411-1426
21. Hayette S., Morle L., Bozon M., Ghanem A., Risinger M., Korsgren C., Tanner M.J., Fattoum S., Cohen C.M., and Delaunay J. A point mutation in the protein 4.2 gene (allele 4.2 Tozeur) associated with hereditary haemolytic anaemia. Br. J. Haematol. 89 (1995) 762-770
22. Bouhassira E.E., Schwartz R.S., Yawata Y., Ata K., Kanzaki A., Qiu J.J., Nagel R.L., and Rybicki A.C. An alanine-to-threonine substitution in protein 4.2 cDNA is associated with a Japanese form of hereditary hemolytic anemia (protein 4.2NIPPON). Blood 79 (1992) 1846-1854
23. Kanzaki A., Yasunaga M., Okamoto N., Inoue T., Yawata A., Wada H., Andoh A., Hodohara K., Fujiyama Y., Bamba T., et al. Band 4.2 Shiga: 317 CGC->TGC in compound heterozygotes with 142 GCT → ACT results in band 4.2 deficiency and microspherocytosis. Br. J. Haematol. 91 (1995) 333-340
24. Takaoka Y., Ideguchi H., Matsuda M., Sakamoto N., Takeuchi T., and Fukumaki Y. A novel mutation in the erythrocyte protein 4.2 gene of Japanese patients with hereditary spherocytosis (protein 4.2 Fukuoka). Br. J. Haematol. 88 (1994) 527-533
25. Matsuda M., Hatano N., Ideguchi H., Takahira H., and Fukumaki Y. A novel mutation causing an aberrant splicing in the protein 4.2 gene associated with hereditary spherocytosis (protein 4.2Notame). Hum. Mol. Genet. 4 (1995) 1187-1191
26. Beauchamp-Nicoud A., Morle L., Lutz H.U., Stammler P., Agulles O., Petermann-Khder R., Iolascon A., Perrotta S., Cynober T., Tchernia G., Delaunay J., and Baudin-Creuza V. Heavy transfusions and presence of an anti-protein 4.2 antibody in 4. 2(-) hereditary spherocytosis (949delG). Haematologica 85 (2000) 19-24
27. Akker E.v.d., Satchwell T.J., Flatt J.F., Pellegrin S., Maigre M., Sessions R.B., Daniels G., Delaunay J., Bruce L.J., and Toye A.M. Alterations in the band3/Rh Protein Complex in Erythrocyte Membranes of Protein 4.2 (Chartres) deficient Cells Occur Late during Erythropoiesis. Blood 112 (2008) 1187 [Abstract 3460]
28. Toye A.M., Williamson R.C., Khanfar M., Bader-Meunier B., Cynober T., Thibault M., Tchernia G., Dechaux M., Delaunay J., and Bruce L.J. Band 3 Courcouronnes (Ser667Phe): a trafficking mutant differentially rescued by wild-type band 3 and glycophorin A. Blood 111 (2008) 5380-5389
29. Perrotta S., Iolascon A., Polito R., d'Urzo G., Conte M.L., and Miraglia del Giudice E. 4.2 Nippon mutation in a non-Japanese patient with hereditary spherocytosis. Haematologica 84 (1999) 660-662
30. Kanzaki A., Yawata Y., Yawata A., Inoue T., Okamoto N., Wada H., Harano T., Harano K., Wilmotte R., Hayette S., et al. Band 4.2 Komatsu: 523 GAT → TAT (175 Asp → Tyr) in exon 4 of the band 4.2 gene associated with total deficiency of band 4.2, hemolytic anemia with ovalostomatocytosis and marked disruption of the cytoskeletal network. Int. J. Hematol. 61 (1995) 165-178
31. Su Y., Ding Y., Jiang M., Hu X., and Zhang Z. Protein 4.2 Komatsu (D175Y) associated with the lack of interaction with ankyrin in human red blood cells. Blood Cells Mol. Dis. 38 (2007) 221-228
32. Alloisio N., Texier P., Vallier A., Ribeiro M.L., Morle L., Bozon M., Bursaux E., Maillet P., Goncalves P., Tanner M.J., Tamagnini G., and Delaunay J. Modulation of clinical expression and band 3 deficiency in hereditary spherocytosis. Blood 90 (1997) 414-420
33. Kanzaki A., Hayette S., Morle L., Inoue F., Matsuyama R., Inoue T., Yawata A., Wada H., Vallier A., Alloisio N., Yawata Y., and Delaunay J. Total absence of protein 4.2 and partial deficiency of band 3 in hereditary spherocytosis. Br. J. Haematol. 99 (1997) 522-530
34. Williamson R.C., and Toye A.M. Glycophorin A: band 3 aid. Blood Cells Mol. Dis. 41 (2008) 35-43
35. Bruce L.J. Red cell membrane transport abnormalities. Curr. Opin. Hematol. 15 (2008) 184-190
36. Zhang D., Kiyatkin A., Bolin J.T., and Low P.S. Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3. Blood 96 (2000) 2925-2933
37. Bruce L.J., Beckmann R., Ribeiro M.L., Peters L.L., Chasis J.A., Delaunay J., Mohandas N., Anstee D.J., and Tanner M.J. A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood 101 (2003) 4180-4188
38. Bennett V., and Stenbuck P.J. Association between ankyrin and the cytoplasmic domain of band 3 isolated from the human erythrocyte membrane. J. Biol. Chem. 255 (1980) 6424-6432
39. Ribeiro M.L., Alloisio N., Almeida H., Gomes C., Texier P., Lemos C., Mimoso G., Morle L., Bey-Cabet F., Rudigoz R.C., Delaunay J., and Tamagnini G. Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3. Blood 96 (2000) 1602-1604
40. Peters L.L., Shivdasani R.A., Liu S.C., Hanspal M., John K.M., Gonzalez J.M., Brugnara C., Gwynn B., Mohandas N., Alper S.L., Orkin S.H., and Lux S.E. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell 86 (1996) 917-927
41. Inaba M., Yawata A., Koshino I., Sato K., Takeuchi M., Takakuwa Y., Manno S., Yawata Y., Kanzaki A., Sakai J., Ban A., Ono K., and Maede Y. Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J. Clin. Invest. 97 (1996) 1804-1817
42. Rybicki A.C., Schwartz R.S., Hustedt E.J., and Cobb C.E. Increased rotational mobility and extractability of band 3 from protein 4.2-deficient erythrocyte membranes: evidence of a role for protein 4.2 in strengthening the band 3-cytoskeleton linkage. Blood 88 (1996) 2745-2753
43. Inoue T., Kanzaki A., Yawata A., Tsuji A., Ata K., Okamoto N., Wada H., Higo I., Sugihara T., Yamada O., et al. Electron microscopic and physicobiochemical studies on disorganization of the cytoskeletal network and integral protein (band 3) in red cells of band 4.2 deficiency with a mutation (codon 142: GCT → ACT). Int. J. Hematol. 59 (1994) 157-175
44. Yawata Y., Yawata A., Kanzaki A., Inoue T., Okamoto N., Uehira K., Yasunaga M., and Nakamura Y. Electron microscopic evidence of impaired intramembrane particles and instability of the cytoskeletal network in band 4.2 deficiency in human red cells. Cell Motil. Cytoskelet. 33 (1996) 95-105
45. Rybicki A.C., Qiu J.J., Musto S., Rosen N.L., Nagel R.L., and Schwartz R.S. Human erythrocyte protein 4.2 deficiency associated with hemolytic anemia and a homozygous 40glutamic acid → lysine substitution in the cytoplasmic domain of band 3 (band 3Montefiore). Blood 81 (1993) 2155-2165
46. Inoue T., Kanzaki A., Kaku M., Yawata A., Takezono M., Okamoto N., Wada H., Sugihara T., Yamada O., Katayama Y., Nagata N., and Yawata Y. Homozygous missense mutation (band 3 Fukuoka: G130R): a mild form of hereditary spherocytosis with near-normal band 3 content and minimal changes of membrane ultrastructure despite moderate protein 4.2 deficiency. Br. J. Haematol. 102 (1998) 932-939
47. Jarolim P., Palek J., Rubin H.L., Prchal J.T., Korsgren C., and Cohen C.M. Band 3 Tuscaloosa: Pro327-Arg327 substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2. Blood 80 (1992) 523-529
48. Bustos S.P., and Reithmeier R.A. Structure and stability of hereditary spherocytosis mutants of the cytosolic domain of the erythrocyte anion exchanger 1 protein. Biochemistry 45 (2006) 1026-1034
49. Zhou Z., DeSensi S.C., Stein R.A., Brandon S., Song L., Cobb C.E., Hustedt E.J., and Beth A.H. Structure of the cytoplasmic domain of erythrocyte band 3 hereditary spherocytosis variant P327R: band 3 Tuscaloosa. Biochemistry 46 (2007) 10248-10257
50. Rybicki A.C., Musto S., and Schwartz R.S. Identification of a band-3 binding site near the N-terminus of erythrocyte membrane protein 4.2. Biochem. J. 309 Pt 2 (1995) 677-681
51. Bhattacharyya R., Das A.K., Moitra P.K., Pal B., Mandal I., and Basu J. Mapping of a palmitoylatable band 3-binding domain of human erythrocyte membrane protein 4.2. Biochem. J. 340 Pt 2 (1999) 505-512
52. Su Y., Ding Y., Jiang M., Jiang W., Hu X., and Zhang Z. Associations of protein 4.2 with band 3 and ankyrin. Mol. Cell. Biochem. 289 (2006) 159-166
53. Peters L.L., Jindel H.K., Gwynn B., Korsgren C., John K.M., Lux S.E., Mohandas N., Cohen C.M., Cho M.R., Golan D.E., and Brugnara C. Mild spherocytosis and altered red cell ion transport in protein 4. 2-null mice. J. Clin. Invest. 103 (1999) 1527-1537
54. De Franceschi L., Olivieri O., Miraglia del Giudice E., Perrotta S., Sabato V., Corrocher R., and Iolascon A. Membrane cation and anion transport activities in erythrocytes of hereditary spherocytosis: effects of different membrane protein defects. Am. J. Hematol. 55 (1997) 121-128
55. Malik S., Sami M., and Watts A. A role for band 4.2 in human erythrocyte band 3 mediated anion transport. Biochemistry 32 (1993) 10078-10084
56. Ding Y., Casey J.R., and Kopito R.R. The major kidney AE1 isoform does not bind ankyrin (Ank1) in vitro. An essential role for the 79 NH2-terminal amino acid residues of band 3. J. Biol. Chem. 269 (1994) 32201-32208
57. Lux S.E., Tse W.T., Menninger J.C., John K.M., Harris P., Shalev O., Chilcote R.R., Marchesi S.L., Watkins P.C., Bennett V., et al. Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature 345 (1990) 736-739
58. Rybicki A.C., Musto S., and Schwartz R.S. Decreased content of protein 4.2 in ankyrin-deficient normoblastosis (nb/nb) mouse red blood cells: evidence for ankyrin enhancement of protein 4.2 membrane binding. Blood 86 (1995) 3583-3589
59. Stefanovic M., Markham N.O., Parry E.M., Garrett-Beal L.J., Cline A.P., Gallagher P.G., Low P.S., and Bodine D.M. An 11-amino acid beta-hairpin loop in the cytoplasmic domain of band 3 is responsible for ankyrin binding in mouse erythrocytes. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13972-13977
60. Mawby W.J., Holmes C.H., Anstee D.J., Spring F.A., and Tanner M.J. Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3. Biochem. J. 304 Pt 2 (1994) 525-530
61. Oldenborg P.A., Zheleznyak A., Fang Y.F., Lagenaur C.F., Gresham H.D., and Lindberg F.P. Role of CD47 as a marker of self on red blood cells. Science 288 (2000) 2051-2054
62. Cartron J.P. RH blood group system and molecular basis of Rh-deficiency. Baillieres Best Pract. Res. Clin. Haematol. 12 (1999) 655-689
63. Dahl K.N., Westhoff C.M., and Discher D.E. Fractional attachment of CD47 (IAP) to the erythrocyte cytoskeleton and visual colocalization with Rh protein complexes. Blood 101 (2003) 1194-1199
64. Lindberg F.P., Gresham H.D., Schwarz E., and Brown E.J. Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding. J. Cell Biol. 123 (1993) 485-496
65. Chin-Yee I., Arya N., and d'Almeida M.S. The red cell storage lesion and its implication for transfusion. Transfus. Sci. 18 (1997) 447-458
66. Bessos H., and Seghatchian J. Red cell storage lesion: the potential impact of storage-induced CD47 decline on immunomodulation and the survival of leucofiltered red cells. Transfus. Apher. Sci. 32 (2005) 227-232
67. D'Amici G.M., Rinalducci S., and Zolla L. Proteomic analysis of RBC membrane protein degradation during blood storage. J. Proteome Res. 6 (2007) 3242-3255
68. Han B.G., Nunomura W., Takakuwa Y., Mohandas N., and Jap B.K. Protein 4.1R core domain structure and insights into regulation of cytoskeletal organization. Nat. Struct. Biol. 7 (2000) 871-875
69. Nunomura W., Takakuwa Y., Parra M., Conboy J., and Mohandas N. Regulation of protein 4.1R, p55, and glycophorin C ternary complex in human erythrocyte membrane. J. Biol. Chem. 275 (2000) 24540-24546
70. Jons T., and Drenckhahn D. Identification of the binding interface involved in linkage of cytoskeletal protein 4.1 to the erythrocyte anion exchanger. EMBO J. 11 (1992) 2863-2867
71. Diakowski W., Grzybek M., and Sikorski A.F. Protein 4.1, a component of the erythrocyte membrane skeleton and its related homologue proteins forming the protein 4.1/FERM superfamily. Folia Histochem. Cytobiol. 44 (2006) 231-248
72. Lombardo C.R., Willardson B.M., and Low P.S. Localization of the protein 4.1-binding site on the cytoplasmic domain of erythrocyte membrane band 3. J. Biol. Chem. 267 (1992) 9540-9546
73. Yawata A., Kanzaki A., Gilsanz F., Delaunay J., and Yawata Y. A markedly disrupted skeletal network with abnormally distributed intramembrane particles in complete protein 4.1-deficient red blood cells (allele 4.1 Madrid): implications regarding a critical role of protein 4.1 in maintenance of the integrity of the red blood cell membrane. Blood 90 (1997) 2471-2481
74. Salomao M., Zhang X., Yang Y., Lee S., Hartwig J.H., Chasis J.A., Mohandas N., and An X. Protein 4.1R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 8026-8031
75. Fennell Jr. R.L., and Soslau G. Zinc ions and alkaline pH alter the phosphorylated state of proteins 3 and 4.2 in human erythrocyte membranes. Thromb. Res. 66 (1992) 637-647
76. Fennell Jr. R.L., Rybicki A.C., Schwartz R.S., and Soslau G. Characterization of the phosphorylated state of protein 4.2 from a patient partially deficient in protein 4.2. Thromb. Res. 66 (1992) 629-636
77. Suzuki K., Ikebuchi H., and Terao T. Mercuric and cadmium ions stimulate phosphorylation of band 4.2 protein on human erythrocyte membranes. J. Biol. Chem. 260 (1985) 4526-4530
78. Koch P.A., Gardner F.H., Gartrell Jr. J.E., and Carter Jr. J.R. Biogenesis of erythrocyte membrane proteins. In vitro studies with rabbit reticulocytes. Biochim. Biophys. Acta 389 (1975) 177-187
79. Southcott M.J., Tanner M.J., and Anstee D.J. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 93 (1999) 4425-4435
80. Bony V., Gane P., Bailly P., and Cartron J.P. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br. J. Haematol. 107 (1999) 263-274
81. Gane P., Le Van Kim C., Bony V., El Nemer W., Mouro I., Nicolas V., Colin Y., and Cartron J.P. Flow cytometric analysis of the association between blood group-related proteins and the detergent-insoluble material of K562 cells and erythroid precursors. Br. J. Haematol. 113 (2001) 680-688
82. Chang H., Langer P.J., and Lodish H.F. Asynchronous synthesis of erythrocyte membrane proteins. Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 3206-3210
83. Woods C.M., Boyer B., Vogt P.K., and Lazarides E. Control of erythroid differentiation: asynchronous expression of the anion transporter and the peripheral components of the membrane skeleton in AEV-and S13-transformed cells. J. Cell Biol. 103 (1986) 1789-1798
84. Woods C.M., and Lazarides E. The erythroid membrane skeleton: expression and assembly during erythropoiesis. Annu. Rev. Med. 39 (1988) 107-122
85. Lehnert M.E., and Lodish H.F. Unequal synthesis and differential degradation of alpha and beta spectrin during murine erythroid differentiation. J. Cell Biol. 107 (1988) 413-426
86. Wada H., Kanzaki A., Yawata A., Inoue T., Kaku M., Takezono M., Sugihara T., Yamada O., and Yawata Y. Late expression of red cell membrane protein 4.2 in normal human erythroid maturation with seven isoforms of the protein 4.2 gene. Exp. Hematol. 27 (1999) 54-62
87. Leberbauer C., Boulme F., Unfried G., Huber J., Beug H., and Mullner E.W. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood 105 (2005) 85-94
88. Griffin M., Casadio R., and Bergamini C.M. Transglutaminases: nature's biological glues. Biochem. J. 368 (2002) 377-396
89. Grenard P., Bates M.K., and Aeschlimann D. Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z. J. Biol. Chem. 276 (2001) 33066-33078
90. Akimov S.S., Krylov D., Fleischman L.F., and Belkin A.M. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J. Cell Biol. 148 (2000) 825-838
91. Hwang K.C., Gray C.D., Sivasubramanian N., and Im M.J. Interaction site of GTP binding Gh (transglutaminase II) with phospholipase C. J. Biol. Chem. 270 (1995) 27058-27062
92. Casadio R., Polverini E., Mariani P., Spinozzi F., Carsughi F., Fontana A., Polverino de Laureto P., Matteucci G., and Bergamini C.M. The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur. J. Biochem. 262 (1999) 672-679
93. Azim A.C., Marfatia S.M., Korsgren C., Dotimas E., Cohen C.M., and Chishti A.H. Human erythrocyte dematin and protein 4.2 (pallidin) are ATP binding proteins. Biochemistry 35 (1996) 3001-3006
94. Pinkas D.M., Strop P., Brunger A.T., and Khosla C. Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol. 5 (2007) e327